No black box warning on record for Juxtapid

As of the latest FDA labeling reviewed, Juxtapid (LOMITAPIDE MESYLATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Juxtapid medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity: May cause fetal harm. Advise females of reproductive potential of the potential risk to the fetus and to use effective contraception. Discontinue JUXTAPID if pregnancy detected ( 5.3 ). Gastrointestinal adverse reactions occur in 93% of adult and 72% of pediatric patients and could affect absorption of concomitant oral medications ( 5.5 ). 5.1 Risk

No black box warning on record for Juxtapid

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity: May cause fetal harm. Advise females of reproductive potential of the potential risk to the fetus and to use effective contraception. Discontinue JUXTAPID if pregnancy detected ( 5.3 ). Gastrointestinal adverse reactions occur in 93% of adult and 72% of pediatric patients and could affect absorption of concomitant oral medications ( 5.5 ). 5.1 Risk

Juxtapid Black Box Warning

No black box warning on record for Juxtapid

Other warnings & precautions

Juxtapid Black Box Warning

No black box warning on record for Juxtapid

Other warnings & precautions